| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,869 |
5,904 |
$629K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,081 |
4,472 |
$330K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
3,454 |
3,019 |
$288K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
2,218 |
1,899 |
$272K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
715 |
615 |
$186K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
1,333 |
1,085 |
$148K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,538 |
1,315 |
$57K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
802 |
640 |
$39K |
| 99051 |
|
4,881 |
4,345 |
$24K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
299 |
265 |
$16K |
| 87486 |
|
742 |
633 |
$16K |
| 87581 |
|
743 |
635 |
$16K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
833 |
741 |
$14K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
796 |
638 |
$13K |
| 99072 |
|
3,344 |
2,844 |
$10K |
| 87640 |
|
507 |
386 |
$9K |
| S9088 |
Services provided in an urgent care center (list in addition to code for service) |
4,088 |
3,526 |
$8K |
| 36415 |
Collection of venous blood by venipuncture |
2,470 |
2,031 |
$5K |
| 87541 |
|
209 |
199 |
$5K |
| 87481 |
|
232 |
170 |
$4K |
| 80053 |
Comprehensive metabolic panel |
603 |
490 |
$4K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
700 |
602 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
213 |
134 |
$2K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
144 |
133 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
112 |
101 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
261 |
228 |
$2K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
22 |
18 |
$1K |
| 90756 |
|
44 |
41 |
$1K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
44 |
36 |
$947.33 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
45 |
37 |
$947.33 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
64 |
54 |
$932.18 |
| 87529 |
|
18 |
12 |
$621.03 |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
16 |
12 |
$568.62 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
25 |
25 |
$526.29 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
13 |
12 |
$498.44 |
| 90674 |
|
14 |
13 |
$444.21 |
| 81003 |
|
330 |
284 |
$432.17 |
| 97760 |
|
15 |
13 |
$400.96 |
| 87511 |
|
13 |
13 |
$294.72 |
| 87500 |
|
16 |
12 |
$284.20 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
12 |
12 |
$280.69 |
| 87653 |
|
16 |
12 |
$256.13 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
14 |
14 |
$161.98 |
| 96127 |
|
42 |
39 |
$141.21 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
14 |
12 |
$135.77 |
| 36416 |
|
12 |
12 |
$76.00 |
| 99000 |
|
1,728 |
1,475 |
$23.34 |
| G8484 |
Influenza immunization was not administered, reason not given |
363 |
329 |
$0.00 |
| 3046F |
|
34 |
24 |
$0.00 |
| 3044F |
|
272 |
219 |
$0.00 |
| 91301 |
|
20 |
16 |
$0.00 |